Physician profile
Christopher Chow
NPI 1619985181
$8,616.47
in general payments reported to CMS, 2019-2025
34 companies · $2,448 in 2025
The $2,448 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,854 · 2020: $289 · 2021: $437 · 2022: $470 · 2023: $1,834 · 2024: $1,285 · 2025: $2,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,272 · Consulting Fee: $750 · Travel and Lodging: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,271.98 |
| Consulting Fee | $750.00 |
| Travel and Lodging | $544.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $1,536.00 | 2019 | |
| Treace Medical Concepts, INC. | $1,497.65 | 2022-2025 | |
| Advanced Oxygen Therapy INC. | $1,283.40 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Ibsa Pharma INC. | $1,075.83 | 2022-2024 | Licart, Tirosint, Licart |
| Stryker Corporation | $563.64 | 2022-2025 | Augment Injectable, Prostep, Easyfuse |
| Smith+Nephew, INC. | $390.91 | 2019-2024 | Collagenase Santyl, Grafix Pl |
| Horizon Therapeutics Plc | $380.13 | 2021-2023 | Krystexxa |
| Kowa Pharmaceuticals America, INC. | $180.29 | 2022-2023 | Seglentis |
| Paratek Pharmaceuticals, INC. | $142.45 | 2021-2025 | Nuzyra |
| Kerecis Limited | $141.17 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Lifenet Health | $133.69 | 2025 | Theragenesis Wound Matrix |
| Merck Sharp & Dohme LLC | $125.00 | 2020 | |
| Gilead Sciences, INC. | $125.00 | 2019 | |
| Misonix INC | $118.47 | 2021 | |
| Sanara Medtech INC. | $117.34 | 2024 | Celleraterx |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $109.72 | 2025 | Krystexxa |
| Pfizer INC. | $83.63 | 2019-2020 | |
| Nevro Corp. | $81.54 | 2021-2024 | Senza |
| Depuy Synthes Sales INC. | $81.00 | 2021 | |
| Wright Medical Technology, INC. | $66.26 | 2019-2020 | |
| Medtronic, INC. | $57.48 | 2021 | |
| Averitas Pharma INC. | $48.97 | 2024 | Qutenza |
| Zimmer Biomet Holdings, INC. | $35.96 | 2021 | |
| Paragon 28, INC. | $30.18 | 2025 | Precision Mis Bunion |
| Bioventus LLC | $28.92 | 2024 | Exogen Ultrasound Bone Healing System |
| Solventum Corporation | $28.02 | 2024 | Activ.A.C., Promogran Prisma |
| Vertex Pharmaceuticals Incorporated | $24.94 | 2025 | |
| Orthofix Medical, INC. | $21.92 | 2025 | Physio-Stim |
| Kci USA, INC. | $20.59 | 2023 | Prevena Restor Arthroform, V.A.C.Via, Activ.A.C. |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.51 | 2022 | |
| Integra Lifesciences Corporation | $18.85 | 2020 | |
| Organogenesis INC. | $17.48 | 2023 | Puraply |
| Fidia Pharma USA INC. | $15.41 | 2019 | |
| Daiichi Sankyo INC. | $14.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.